PubRank

Elke M G J de Jong

Author PubWeight™ 29.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005 1.85
2 Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis. Arch Dermatol 2010 1.77
3 Current and future treatment options for acne. J Dermatolog Treat 2006 1.60
4 Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS One 2009 1.06
5 Scleredema diabeticorum case series: successful treatment with UV-A1. Arch Dermatol 2008 1.01
6 Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol 2009 0.92
7 Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis. Arch Dermatol 2008 0.91
8 Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int 2007 0.91
9 Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. Toxicol Lett 2013 0.90
10 Psychological distress in patients with morphea and eosinophilic fasciitis. Arch Dermatol 2009 0.88
11 What patients think about E-health: patients' perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis. Clin Rheumatol 2013 0.88
12 Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review. Acta Derm Venereol 2008 0.88
13 Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 2003 0.87
14 Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008 0.86
15 Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis. Acta Derm Venereol 2009 0.85
16 Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. Am J Clin Dermatol 2009 0.84
17 Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin. J Am Acad Dermatol 2004 0.83
18 Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects. J Am Acad Dermatol 2004 0.80
19 Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists. Br J Clin Pharmacol 2011 0.79
20 INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. Am J Surg Pathol 2005 0.79
21 Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate. Acta Derm Venereol 2016 0.79
22 Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice. J Am Acad Dermatol 2012 0.78
23 Expression of p14ARF, p16INK4a and p53 in relation to HPV in (pre-)malignant squamous skin tumours. J Cell Mol Med 2008 0.78
24 Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens. Arch Dermatol 2007 0.78
25 Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies. J Drugs Dermatol 2014 0.78
26 Effectiveness of adalimumab dose escalation, combination therapy of adalimumab with methotrexate, or both in patients with psoriasis in daily practice. J Dermatolog Treat 2013 0.78
27 P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod Pathol 2003 0.77
28 Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized Scleroderma. Acta Derm Venereol 2016 0.77
29 Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot study. Eur J Dermatol 2008 0.77
30 Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients. Arch Dermatol 2002 0.77
31 Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis. Acta Derm Venereol 2006 0.76
32 Genotype-phenotype correlations in a prospective cohort study of paediatric plaque psoriasis: lack of correlation between HLA-C*06 and family history of psoriasis. Acta Derm Venereol 2014 0.76
33 Tailored Therapist-Guided Internet-Based Cognitive Behavioral Treatment for Psoriasis: A Randomized Controlled Trial. Psychother Psychosom 2016 0.76
34 Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients. Exp Dermatol 2008 0.75
35 Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients. Arch Dermatol 2003 0.75
36 Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review. Acta Derm Venereol 2016 0.75
37 Measuring the Therapeutic Relationship in Internet-Based Interventions. Psychother Psychosom 2015 0.75
38 Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement. Acta Derm Venereol 2009 0.75
39 [Is psoriasis a dependent cardiovascular risk factor?]. Ned Tijdschr Geneeskd 2013 0.75
40 Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis. Rheumatology (Oxford) 2009 0.75
41 A phase II multicenter clinical trial of systemic bexarotene in psoriasis. J Am Acad Dermatol 2004 0.75
42 Body attention, ignorance and awareness scale: assessing relevant concepts for physical and psychological functioning in psoriasis. Acta Derm Venereol 2015 0.75
43 Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot study. J Dermatolog Treat 2008 0.75